ethanolamine has been researched along with Diabetes Mellitus, Type 2 in 4 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metabolic disorders such as type 2 diabetes, fatty liver disease, hyperlipidemia, and obesity commonly co-occur but clinical treatment options do not effectively target all disorders." | 2.44 | Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice. ( Alexopoulos, SJ; Beretta, M; Byrne, FL; Cantley, J; Chen, SY; Garcia, CJ; Hoehn, KL; Larance, M; Olzomer, EM; Philp, A; Salamoun, JM; Santos, WL; Shah, DP; Smith, GC; Turner, N, 2024) |
| "Diabetic peripheral neuropathy (DPN), diabetic kidney disease (DKD), and diabetic retinopathy (DR) contribute to significant morbidity and mortality in diabetes patients." | 1.51 | Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes. ( Abcouwer, SF; Backus, C; Brosius, FC; Feldman, EL; Hayes, JM; Hinder, LM; Kayampilly, P; Lin, CM; O'Brien, PD; Pennathur, S; Rumora, AE; Sas, KM; Shanmugam, S; Zhang, H, 2019) |
| "Early diabetic kidney disease (DKD) is characterized by renal hypertrophy and albuminuria." | 1.48 | Niclosamide ethanolamine improves kidney injury in db/db mice. ( Ge, N; Han, P; Li, S; Shao, M; Song, G; Sun, H; Wang, W; Yi, T; Yu, X; Zhan, H; Zhang, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, H | 1 |
| E-Lacerda, RR | 1 |
| Schertzer, JD | 1 |
| Chen, SY | 1 |
| Beretta, M | 1 |
| Olzomer, EM | 1 |
| Alexopoulos, SJ | 1 |
| Shah, DP | 1 |
| Byrne, FL | 1 |
| Salamoun, JM | 1 |
| Garcia, CJ | 1 |
| Smith, GC | 1 |
| Larance, M | 1 |
| Philp, A | 1 |
| Turner, N | 1 |
| Santos, WL | 1 |
| Cantley, J | 1 |
| Hoehn, KL | 1 |
| Han, P | 1 |
| Zhan, H | 1 |
| Shao, M | 1 |
| Wang, W | 1 |
| Song, G | 1 |
| Yu, X | 1 |
| Zhang, C | 1 |
| Ge, N | 1 |
| Yi, T | 1 |
| Li, S | 1 |
| Sun, H | 1 |
| Hinder, LM | 1 |
| Sas, KM | 1 |
| O'Brien, PD | 1 |
| Backus, C | 1 |
| Kayampilly, P | 1 |
| Hayes, JM | 1 |
| Lin, CM | 1 |
| Zhang, H | 1 |
| Shanmugam, S | 1 |
| Rumora, AE | 1 |
| Abcouwer, SF | 1 |
| Brosius, FC | 1 |
| Pennathur, S | 1 |
| Feldman, EL | 1 |
4 other studies available for ethanolamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Obesity promotes a leaky gut, inflammation and pre-diabetes by lowering gut microbiota that metabolise ethanolamine.
Topics: Diabetes Mellitus, Type 2; Ethanolamine; Gastrointestinal Microbiome; Humans; Inflammation; Obesity; | 2023 |
Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice.
Topics: Animals; Caloric Restriction; Diabetes Mellitus, Type 2; Ethanolamine; Ethanolamines; Female; Mice; | 2024 |
Niclosamide ethanolamine improves kidney injury in db/db mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ethanol | 2018 |
Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopa | 2019 |